-+ 0.00%
-+ 0.00%
-+ 0.00%

TREVI THERAPEUTICS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $25 FROM $21

Reuters·04/21/2026 03:13:16

Please log in to view news